Teva Pharmacueticals is giving investors several reasons to buy - MarketBeat
Teva- Pharmaceutical Industries Ltd. (TEVA) Stock News | Stock Titan
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharma: Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO, ET HealthWorld
Teva Pharmaceutical (TEVA) Stock Message Board | InvestorsHub
Teva Pharma CEO Richard Francis on Q4 earnings
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership | Business Wire
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva CEO stands down during troubled times - MedCity News
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
